EACVI Premium Access

Rate of transesophageal echocardiography related complications during 1229 TEE-guided structural heart disease procedures

Topic: Intraoperative and Interventional Echocardiography

Presentation

About the speaker

Doctor Ellen Kronzer

Mayo Clinic Hospital-Rochester, Rochester (United States of America)
0 follower

5 more presentations in this session

The MIDA quantitative international registry: prognostic implications of moderately elevated pulmonary artery pressure

Speaker: Doctor B. Essayagh (Rochester, US)

Thumbnail

Comparison of mitral regurgitant volume assessment between proximal flow convergence and volumetric methods in patients with significant primary mitral regurgitation

Speaker: Doctor A. Altes (Lille, FR)

Thumbnail

Acute and chronic changes in LV performance in patients with primary severe mitral regurgitation undergoing percutaneous mitral valve repair

Speaker: Doctor E. Galli (Rennes, FR)

Thumbnail

Magnetic resonance derived regurgitant fraction, 3D vena contracta area, and B-natriuretic peptide: the most accurate prognostic markers in patients with chronic asymptomatic aortic regurgitation

Speaker: Doctor R. Kockova (Prague, CZ)

Thumbnail

Increasing transvalvular flow with passive leg rise as an add-on to dobutamine in patients with paradoxical low-flow, low-gradient aortic stenosis

Speaker: Doctor E. Buffle (Bern, CH)

Thumbnail

Access the full session

Advances in heart valve imaging

Speakers: Doctor E. Kronzer, Doctor B. Essayagh, Doctor A. Altes, Doctor E. Galli, Doctor R. Kockova...
Thumbnail

About the event

Image

EuroEcho 2021

9 December - 11 December 2021

Sessions Presentations

Related content

Open Access

Mode of intervention in mitral regurgitation.

28 August 2021

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

ESC Premium Access

Treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe: baseline demographics from the multinational observational SANTORINI study

27 August 2021

This platform is supported by

logo Novo Nordisk